Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US1011371077
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000C0LW92
BSX
Boston Scientific Corp
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Medical Devices · THEMEFOLIO: $HLTH
NAME
Boston Scientific Corp
ISIN
US1011371077
TICKER
BSX
MIC
XNYS
REUTERS
BSX.N
BLOOMBERG
BSX US
Di., 17.03.2026       Boston Scientific
US1011371077

LOS ANGELES, March 17, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX) have opportunity to lead the securities fraud class action lawsuit....
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 17.03.2026       Boston Scientific
US1011371077

NEW YORK, March 17, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX). Shareholders who purchased shares of BSX during the class period listed are encourag...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 17.03.2026       Boston Scientific
US1011371077

NEW YORK, March 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of  common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (t...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 16.03.2026       Boston Scientific
US1011371077

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Boston Scientific between July 23, 2025 and February 3, 2026 and would like to discuss your legal rights, call Faruqi &am...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 16.03.2026       Boston Scientific
US1011371077

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026, both dates inclusive (the “Class Period”), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scientific class action lawsuit. Captioned Troike v....
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 16.03.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - March 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"). A class action lawsuit has already b...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
So., 15.03.2026       Boston Scientific
US1011371077

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Boston Scientific between July 23, 2025 and February 3, 2026 and would like to discuss your legal rights, call Faruqi &...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 13.03.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - March 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"). A class action lawsuit has already been...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 13.03.2026       Boston Scientific
US1011371077

NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inqui...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Boston Scientific
US1011371077

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 4, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025 and February 3, 2026, inc...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 12.03.2026       Boston Scientific
US1011371077

SAN DIEGO, March 12, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scient...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Boston Scientific
US1011371077

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Boston Scientific between July 23, 2025 and February 3, 2026 and would like to discuss your legal rights, call Faruqi &am...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Boston Scientific
US1011371077

Alert: Claims Focus on Alleged Misrepresentations About U.S. Electrophysiology Procedure GrowthNEW YORK, March 12, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Boston Scientific Corporation (NYSE: BSX) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purcha...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - March 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"). A class action lawsuit has already been file...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mi., 11.03.2026       Boston Scientific
US1011371077

Law Offices of Howard G. Smith reminds investors of the upcoming May 4, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025 and February 3, 2026, inclusive (the “Class Period”). IF YOU...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Boston Scientific
US1011371077

Levi & Korsinsky, LLP alerts investors in Boston Scientific Corporation (NYSE: BSX) of a pending securities class action. Class Period: July 23, 2025 through February 3, 2026. Check if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500. Boston Scientific shares fell $16.12 per s...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Boston Scientific
US1011371077

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Boston Scientific between July 23, 2025 and February 3, 2026 and would like to discuss your legal rights, call Faruqi &...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Boston Scientific
US1011371077

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Boston Scientific Corporation. (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025 and February 3, 2026, inclusive (the “Class Period”). Boston Scientific investors have...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Boston Scientific
US1011371077

NEW YORK, March 10, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX). Shareholders who purchased shares of BSX during the class period listed are encourag...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - March 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"). A class action lawsuit has already been file...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 09.03.2026       Boston Scientific
US1011371077

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025 and February 3, 202...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       Boston Scientific
US1011371077

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or “the Company”) (NYSE: BSX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
So., 08.03.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - March 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"). A class action lawsuit has already been file...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
So., 08.03.2026       Boston Scientific
US1011371077

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Boston Scientific between July 23, 2025 and February 3, 2026 and would like to discuss your legal rights, call Faruqi &...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Sa., 07.03.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - March 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"). A class action lawsuit has already been file...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Boston Scientific
US1011371077

NEW YORK, March 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 202...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Boston Scientific
US1011371077

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025 and February 3, 2026, inclusive (the “Class Period”). Boston Scientific investors have until May 4, 2026 to file a...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Boston Scientific
US1011371077

SAN DIEGO, March 6, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026. Boston Scientific is a global company that develops, manufactures, and markets medi...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Boston Scientific
US1011371077

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026. Boston Scientific describes itself as a “a global company that develops, manufactures, and markets medical devices used across various s...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Boston Scientific
US1011371077

MARLBOROUGH, Mass., March 6, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host an investor event and live webcast on Saturday, March 28, 2026, at 6:30 p.m. ET / 5:30 p.m. CT to discuss key clinical data presented earlier that day at the 75th Annual Scientific Session of the American College of Cardiology. The event will be h...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Boston Scientific
US1011371077

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026. Boston Scientific is a global company that develops, manufactures, and markets medical devices used across various specialti...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 02.03.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - March 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws.On February 4, 2026, Boston Scientific reported fourth-quarter 2025 resu...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Do., 26.02.2026       Boston Scientific
US1011371077

NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 23.02.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE:BSX) concerning potential violations of the federal securities laws.On February 4, 2026, Boston Scientific reported fourth-quarter 2025 r...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 23.02.2026       Boston Scientific
US1011371077

MARLBOROUGH, Mass., Feb. 23, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18, 2026. Smith is a seasoned e...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 20.02.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws.On February 4, 2026, Boston Scientific reported fourth-quarter 2025...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 20.02.2026       Boston Scientific
US1011371077

NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 13.02.2026       Boston Scientific
US1011371077

MARLBOROUGH, Mass., Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney, chairman and chief executive officer, and Kenneth Stein, M.D., senior vice president and global chief medical officer, will participate in a 30-minute...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Di., 10.02.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific Corporation") concerning potential violations of the federal securities laws.On February 4, 2026, Boston Scientific reported fourth-qua...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 09.02.2026       Boston Scientific
US1011371077

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR W...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 09.02.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws.On February 4, 2026, Boston Scientific reported fourth-quarter 2025 r...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.02.2026       Boston Scientific
US1011371077

Law Offices of Howard G. Smith announces an investigation on behalf of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BOSTON SCIENTIFIC CORPORATION (BSX), CONTACT THE LAW OFFICES OF HO...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 06.02.2026       Boston Scientific
US1011371077

The Law Offices of Frank R. Cruz announces an investigation of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BOSTON SCIENTIFIC CORPORATION (BSX), CLICK HERE TO INQUIRE ABOUT P...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Do., 05.02.2026       Boston Scientific
US1011371077

New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws.On February 4, 2026, Boston Scientific reported fourth-quarter 2025 r...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mi., 04.02.2026       Boston Scientific
US1011371077

MARLBOROUGH, Mass., Feb. 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational1 basis and 12.7 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP n...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 16.01.2026       Boston Scientific
US1011371077

NEW YORK and NEW ORLEANS, Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Penumbra, Inc. (NYSE: PEN) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of P...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Do., 15.01.2026       Boston Scientific
US1011371077

Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseasesProvides scaled entry into mechanical thrombectomy and neurovascular, key strategic adjacenciesConference call at 8:00 a.m. ET to discuss details of the transactionMARLBOROUGH, Mass. and ALAMEDA, Calif., Jan. 15, 2026 /P...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 12.01.2026       Boston Scientific
US1011371077

Acquisition to expand urology offerings for people living with overactive bladderMARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held medical technology company focused on the development...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Fr., 02.01.2026       Boston Scientific
US1011371077

MARLBOROUGH, Mass., Jan. 2, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in San Francisco. Mike Mahoney, chairman and chief executive officer, Jon Monson, executive vice president and chief financial officer, and Ken Stein, M.D.,...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink
Mo., 03.11.2025       Boston Scientific
US1011371077

MARLBOROUGH, Mass., Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On November 18,...
Zur Nachricht
Boston Scientific
Charts & Research Termsheets Terminal
Permalink